advertisement

---

Shiokawa M 15

Showing records 1 to 15 | Display all abstracts from Shiokawa M

116723 Three-year efficacy and safety of omidenepag isopropyl in patients with normal tension glaucoma
Inoue K
Japanese Journal of Ophthalmology 2024; 68: 206-210

---

118749 Switching to Brimonidine/Ripasudil Fixed Combination from Brimonidine + Ripasudil
Inoue K
Clinical Ophthalmology 2024; 18: 423-430

---

117964 Glaucoma progression due to refraining examination amid the pandemic of COVID-19
Inoue K
International Ophthalmology 2024; 44: 196

---

118749 Switching to Brimonidine/Ripasudil Fixed Combination from Brimonidine + Ripasudil
Shiokawa M
Clinical Ophthalmology 2024; 18: 423-430

---

116723 Three-year efficacy and safety of omidenepag isopropyl in patients with normal tension glaucoma
Shiokawa M
Japanese Journal of Ophthalmology 2024; 68: 206-210

---

117964 Glaucoma progression due to refraining examination amid the pandemic of COVID-19
Shiokawa M
International Ophthalmology 2024; 44: 196

---

116723 Three-year efficacy and safety of omidenepag isopropyl in patients with normal tension glaucoma
Kunimatsu-Sanuki S
Japanese Journal of Ophthalmology 2024; 68: 206-210

---

117964 Glaucoma progression due to refraining examination amid the pandemic of COVID-19
Kunimatsu-Sanuki S
International Ophthalmology 2024; 44: 196

---

118749 Switching to Brimonidine/Ripasudil Fixed Combination from Brimonidine + Ripasudil
Kunimatsu-Sanuki S; Tomita G
Clinical Ophthalmology 2024; 18: 423-430

---

116723 Three-year efficacy and safety of omidenepag isopropyl in patients with normal tension glaucoma
Kang J
Japanese Journal of Ophthalmology 2024; 68: 206-210

---

117964 Glaucoma progression due to refraining examination amid the pandemic of COVID-19
Ishida K
International Ophthalmology 2024; 44: 196

---

118749 Switching to Brimonidine/Ripasudil Fixed Combination from Brimonidine + Ripasudil
Ishida K
Clinical Ophthalmology 2024; 18: 423-430

---

116723 Three-year efficacy and safety of omidenepag isopropyl in patients with normal tension glaucoma
Uraki T
Japanese Journal of Ophthalmology 2024; 68: 206-210

---

117964 Glaucoma progression due to refraining examination amid the pandemic of COVID-19
Tomita G
International Ophthalmology 2024; 44: 196

---

116723 Three-year efficacy and safety of omidenepag isopropyl in patients with normal tension glaucoma
Tomita G; Ishida K
Japanese Journal of Ophthalmology 2024; 68: 206-210

---